A new treatment has been approved for extensive-stage small cell lung cancer

Дата публикации: 24-09-2026 10:52:46

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved lurbinectedin (Zepzelca) as a new treatment option for adults with extensive-stage small cell lung cancer (SCLC).
The post A new treatment has been approved for extensive-stage small cell lung cancer appeared first on Open Access Government.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	New NHS approval creates new hope for patients with rare blood cancers	0	6.31	17-07-2026
2	NHS rolls out pembrolizumab for women with advanced cervical cancer	0	6.27	25-06-2026
3	Vimseltinib approved in the UK for adults with tenosynovial giant cell tumours	0	5.27	14-08-2026
4	GSK’s B7-H3-targeted antibody-drug conjugate, risvutatug rezetecan, granted Orphan Drug Designation for small-cell lung cancer in Japan	0	14.91	23-03-2026
5	New national cancer board launched to create improvements in cancer care	0	5.1	21-09-2026
6	WHO opens new pathway to child-friendly cancer medicines	0	10.49	07-09-2026
7	FDA approves Welireg-Lenvima combination for advanced RCC	0	10.87	24-09-2026
8	GSK’227, a B7-H3-targeted antibody-drug conjugate, granted Orphan Drug Designation in small-cell lung cancer by the US FDA	0	16.47	10-12-2025
9	How interferon changes cancerous blood stem cells	0	8.88	15-09-2026
10	A new chip can mimic how cancer spreads to other organs	0	7.08	20-08-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7.66. Источник: www.openaccessgovernment.org.